Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-10

FDA Approved: NAFTIFINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved Naftifine hydrochloride topical from Sun Pharmaceutical Industries under an original ANDA for treating common fungal skin infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naftifiline hydrochloride (naftifine hydrochloride)

Snippet

ORIG AP for NAFTIFINE HYDROCHLORIDE (NAFTIFINE HYDROCHLORIDE)